N. J. Prakash

发表

Polyamine Biosynthesis: A Target for Antimetastatic Therapy

P. Sunkara, N. J. Prakash, 1986 .

3 – Inhibitors of Polyamine Biosynthesis as Antitumor and Antimetastatic Agents

P. Sunkara, N. J. Prakash, 1984 .

An essential role for polyamines in tumor metastases

P. Sunkara, A. Rosenberger, N. J. Prakash, 1982, FEBS letters.

Tumor suppression with a combination of alpha-difluoromethyl ornithine and interferon.

A. Sjoerdsma, P. Sunkara, N. J. Prakash, 1983, Science.

4',5'-unsaturated 5'-halogenated nucleosides. Mechanism-based and competitive inhibitors of S-adenosyl-L-homocysteine hydrolase.

M. L. Edwards, P. Sunkara, D. Matthews, 1991, Journal of medicinal chemistry.

Effect of transitional metal ions on (Na+ + K+) ATPase activity and the uptake of norepinephrine and choline by brain synaptosomes

J. Fontana, R. Henkin, N. J. Prakash, 1973 .

Antiretroviral activity of mechanism-based irreversible inhibitors of S-adenosylhomocysteine hydrolase.

G. F. Davis, M. L. Edwards, J. Mccarthy, 1992, Life sciences.

Mechanism of antitumor activity of norspermidine, a structural homologue of spermidine.

P. Sunkara, T. Bowlin, N. J. Prakash, 1988, Advances in experimental medicine and biology.

L-Ornithine decarboxylase:an essential role in early mammalian embryogenesis.

A. Sjoerdsma, J. Fozard, P. Schechter, 1980, Science.

Inhibition of EMT6 tumor growth by interference with polyamine biosynthesis; effects of alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase.

A. Sjoerdsma, P. Schechter, J. Koch-weser, 1980, Life sciences.

Inhibition of murine embryonic development by alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase.

J. Fozard, J. Grove, N. J. Prakash, 1980, European journal of pharmacology.

Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on L1210 leukemia in mice.

P. Schechter, J. Koch-weser, J. Grove, 1978, Cancer research.

Polyamine analogues with antitumor activity.

G. F. Davis, A. Bitonti, J. Dumont, 1990, Journal of medicinal chemistry.

Influence of zinc-ligand mixtures on serum zinc levels in rats.

E. Giroux, N. J. Prakash, 1977, Journal de medecine de Bordeaux et du Sud-Ouest.

Potentiation by alpha-difluoromethylornithine of the activity of 3,4-dihydroxybenzylamine, a tyrosinase-dependent melanolytic agent, against B16 melanoma.

A. Sjoerdsma, P. Sunkara, N. J. Prakash, 1985, Biochemical pharmacology.

Role of polyamines during chromosome condensation of mammalian cells.

P. Sunkara, N. J. Prakash, C. C. Chang, 1983, Cell biology international reports.

Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.

P. Sunkara, N. J. Prakash, P. J. Lachmann, 1985, Cancer research.

Combination Chemotherapy Involving α-Difluoromethylornithine and 1-β-d-Arabinofuranosylcytosine in Murine L1210 Leukemia

P. Sunkara, N. J. Prakash, 1983 .

4′,5′-Unsaturated 5′-Fluoroadenosine Nucleosides: Potent Mechanism-Based Inhibitors of S-Adenosyl-L-homocysteine Hydrolase.

M. L. Edwards, P. Sunkara, D. Matthews, 1989 .

4',5'-Unsaturated-5'-fluoro adenosine nucleosides: potent mechanism-based inhibitors of S-adenosyl-L-homocysteine hydrolase

P. Sunkara, D. Matthews, J. Mccarthy, 1989 .

CombinationChemotherapyInvolvinga-Difluoromethylornithine and 1-ÃŸ-o- Arabinofura nosyIcytosine in Murine L1210 Leukemia

P. Sunkara, N. J. Prakash, 1983 .

Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.

P. Sunkara, A. Rosenberger, N. J. Prakash, 1984, Cancer research.

Tissue-and metal-specific effects of thiolacrylic acids in rats

P. Schechter, E. Giroux, H. Petering, 1983, Biological Trace Element Research.

UNUSUAL EFFECT OF SOME α‐MERCAPTOACRYLIC ACIDS ON METABOLISM OF ZINC IN THE RAT

A. Sjoerdsma, E. Giroux, N. J. Prakash, 1977 .

Failure of oral L-histidine to influence appetite or affect zinc metabolism in man: a double-blind study.

P. Schechter, N. J. Prakash, 1979, The American journal of clinical nutrition.

Ovarian function in the rat following irreversible inhibition of L-ornithine decarboxylase.

J. Fozard, J. Grove, N. J. Prakash, 1980, Life sciences.

Effects of DL-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, on the rat mammary tumour induced by 7,12-dimethylbenz[a]anthracene.

J. Fozard, N. J. Prakash, 1982, Naunyn-Schmiedeberg's archives of pharmacology.

Potentiation of Antitumor Activity of α‐Difluoromethyl Ornithine by the Immunomodulating Peptide Tuftsin

P. Sunkara, Kenji Nishioka, N. J. Prakash, 1983, Annals of the New York Academy of Sciences.

Inhibition of early embryogenic development in mice by alpha-difluoromethyl ornithine, an enzyme-activated irreversible inhibitor of L-ornithine decarboxylase [proceedings].

J. Fozard, J. Grove, N. J. Prakash, 1979, British journal of pharmacology.

Antitumor activity of a novel synthetic polyamine analogue, N,N'-bis-[3-(ethylamino)-propyl]-1-7-heptane diamine: potentiation by polyamine oxidase inhibitors.

M. L. Edwards, A. Sjoerdsma, P. Sunkara, 1990, Anticancer research.